HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wheatley, D. J. Articles by Lewis, S. S. Search for Related Content PubMed PubMed Citation Articles by Wheatley, D. J. Articles by Lewis, S. S.

European Journal of Cardio-Thoracic Surgery, Vol 8, 541-548, Copyright © 1994 by European Association for Cardio-thoracic Surgery

ARTICLES

A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve

DJ Wheatley, FA Crawford, PH Kay, JG Chandler, MD Strong 3rd, JA Strom, PM Shah, WJ Keon, G Copeland 3rd and SS Lewis
Department of Cardiothoracic Surgery, Glasgow Royal Infirmary, Scotland, UK.

Seven hundred and eight adults (age > or = 16 years) with isolated aortic (n = 433) or mitral (n = 275) Ionescu-Shiley Low-Profile (ISLP) pericardial valves were followed at 14 implanting centres in Canada, the United Kingdom, and the United States for a mean of 6.7 years, providing 4,729 patient-years of clinical data. The operative mortality rate was 3.0% for aortic valve replacement (AVR) and 5.5% for mitral valve replacement (MVR) (p = ns). Actuarial patient survival following AVR at 5 years was 81.6%, and 62.9% at 10 years; for MVR patients it was 78.1% at 5 years and 59.6% at 10 years. The ISLP valve appears to have durability comparable to other contemporary bioprosthetic valves. For aortic prostheses, the freedom from structural deterioration was 96.5% at 5 years and 73.7% at 10 years, and 89.7% at 5 years and 62.4% at 10 years for mitral prostheses. Structural deterioration was significantly more frequent following MVR than after AVR (p < 0.05). Structural deterioration was the principal cause for reoperation, but sudden deterioration precluding safe reoperation was not a dominant feature of this series. The ISLP valve appeared to engender more thrombo-embolic events than would be anticipated from earlier studies of pericardial bioprostheses, but was indistinguishable from other tissue valves in its incidence of other valve-related complications. We conclude that ISLP valves now implanted for 7 years or more are entering a phase of increasing structural deterioration, indicating the need for regular clinical and echocardiographic surveillance, and that long-term anticoagulation should be instituted for relatively minimal indications in these patients.

This article has been cited by other articles:

				D. Oswal, C. D. Sudarshan, and P. H. Kay Twenty-three-year survival of a bovine pericardial bioprosthesis J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1127 - 1128. [Full Text]